Clinical Trial Update: ANAVEX2-73 Study in Parkinson's Disease Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial results update for ANAVEX2-73 in Parkinson's disease dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease with Dementia

Drugs mentioned

• ANAVEX2-73 (blarcamesine)

Snippet

Sponsor: Anavex Life Sciences Corp. | Conditions: Parkinsons Disease With Dementia | Phase 2 | Status: COMPLETED